These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20594590)

  • 21. Glucose control and cardiovascular complications: the VA Diabetes Trial.
    Duckworth WC; McCarren M; Abraira C;
    Diabetes Care; 2001 May; 24(5):942-5. PubMed ID: 11347758
    [No Abstract]   [Full Text] [Related]  

  • 22. Glucose control and vascular complications in veterans with type 2 diabetes.
    Duckworth W; Abraira C; Moritz T; Reda D; Emanuele N; Reaven PD; Zieve FJ; Marks J; Davis SN; Hayward R; Warren SR; Goldman S; McCarren M; Vitek ME; Henderson WG; Huang GD;
    N Engl J Med; 2009 Jan; 360(2):129-39. PubMed ID: 19092145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of glucose-lowering agents on vascular outcomes in type 2 diabetes: a critical reappraisal.
    Scheen AJ; Charbonnel B
    Diabetes Metab; 2014 Jun; 40(3):176-85. PubMed ID: 24792220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dangerous blood glucose peaks. Vascular damage even before diabetes].
    MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584214
    [No Abstract]   [Full Text] [Related]  

  • 25. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
    MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
    [No Abstract]   [Full Text] [Related]  

  • 26. [Glycemic control and diabetic complications].
    Yamada Y
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():604-8. PubMed ID: 15999778
    [No Abstract]   [Full Text] [Related]  

  • 27. Is Hemoglobin A1c the Right Outcome for Studies of Diabetes?
    Lipska KJ; Krumholz HM
    JAMA; 2017 Mar; 317(10):1017-1018. PubMed ID: 28125758
    [No Abstract]   [Full Text] [Related]  

  • 28. [Preventing infarct in the diabetic patient. Lowering blood glucose and HbA1c are not enough].
    Reblin T; Seidel D; Stein D; Görtz A; Lander T
    MMW Fortschr Med; 2003 May; 145(19):41. PubMed ID: 12813977
    [No Abstract]   [Full Text] [Related]  

  • 29. Post-prandial hyperglycaemia--the necessity for better control.
    Del Prato S
    Int J Clin Pract Suppl; 2000 Sep; (112):3-8. PubMed ID: 11064944
    [No Abstract]   [Full Text] [Related]  

  • 30. Recognition of fasting or overall hyperglycaemia when starting insulin treatment in patients with type 2 diabetes in general practice.
    Vähätalo M; Rönnemaa T; Viikari J
    Scand J Prim Health Care; 2007 Sep; 25(3):147-53. PubMed ID: 17846932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose control in diabetes: which target level to aim for?
    Laakso M; Cederberg H
    J Intern Med; 2012 Jul; 272(1):1-12. PubMed ID: 22321169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current target values in diabetes not evident for the oldest old. Safety risk with too rigid blood sugar control].
    Fors P
    Lakartidningen; 2009 Jun 10-23; 106(24-25):1639-40. PubMed ID: 19630291
    [No Abstract]   [Full Text] [Related]  

  • 33. Individualizing glycemic targets in type 2 diabetes mellitus.
    Aron D; Conlin PR; Hobbs C; Vigersky RA; Pogach L
    Ann Intern Med; 2011 Sep; 155(5):340-1. PubMed ID: 21893635
    [No Abstract]   [Full Text] [Related]  

  • 34. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ADVANCE and glycaemia thresholds: a need to clarify the statistical approach.
    Currie CJ
    Diabetologia; 2012 Aug; 55(8):2298-9; author reply 2300. PubMed ID: 22610398
    [No Abstract]   [Full Text] [Related]  

  • 36. Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT.
    Terry T; Raravikar K; Chokrungvaranon N; Reaven PD
    Curr Cardiol Rep; 2012 Feb; 14(1):79-88. PubMed ID: 22160862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case study 1: exploring the pharmacologic agents for treatment of type 2 diabetes.
    Martin CL
    Diabetes Educ; 2007; 33 Suppl 1():6S-13S. PubMed ID: 17272803
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current methods of glucose metabolism control in diabetes mellitus].
    Scarpitta AM; Sinagra D
    Recenti Prog Med; 2003 Jan; 94(1):31-40. PubMed ID: 12632998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intensive insulin therapy to prevent the progression of chronic vascular complications in type 2 diabetes mellitus].
    Kishikawa H; Araki E; Wake N; Shichiri M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():140-5. PubMed ID: 12386985
    [No Abstract]   [Full Text] [Related]  

  • 40. Lower baseline glycemia reduces apparent oral agent glucose-lowering efficacy: a meta-regression analysis.
    Bloomgarden ZT; Dodis R; Viscoli CM; Holmboe ES; Inzucchi SE
    Diabetes Care; 2006 Sep; 29(9):2137-9. PubMed ID: 16936168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.